BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201201T080000
DTEND;TZID=Europe/London:20201202T170000
DTSTAMP:20260422T120049
CREATED:20201119T144359Z
LAST-MODIFIED:20201119T144359Z
UID:18456-1606809600-1606928400@staging.medilinkmidlands.com
SUMMARY:Virtual Global Innovation and New Technology Health Event (GIANT) 2020
DESCRIPTION:The GIANT Health Event is an unmissable\, cost-effective global\, virtual gathering for everyone “whose business in health care\, technology\, and innovation”. It’s a vibrant\, engaged global business community and the event enables and commercialises leading Healthtech innovation from around the world. Set to be bigger and better this year as the event goes virtual\, reaching out to a global community of over 177\,000 health tech innovators\, offering more direct business networking services\, and more personalised engagement opportunities. \nMedilink Members will receive a 15% discount which must be booked via this unique link here.  \nWhy not showcase your solutions\, talent and ideas? \nExplore partnerships\, business deals and meet new leads. Discover valuable new partners and make connections that matter. GIANT is the Global Innovation And New Technology event. Accelerating innovation and commercial success: Already established\, GIANT is an unmissable “innovation conference and dynamic trade exhibition”\, showcasing leading health technologies from around the world. Meet and build partnerships with companies ranging from startups to global large corporates and get exposure to leading industry press and media and being interviewed by professional film companies. \nTo find out more please contact GIANT organiser David Wortley\, click here to email. \nIf you have any Medilink discount queries please contact Zoe Heather\, Events & Marketing Communications Manager\, click here to email Zoe.
URL:https://staging.medilinkmidlands.com/event/virtual-global-innovation-and-new-technology-health-event-giant-2020/
CATEGORIES:Other Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201201T110000
DTEND;TZID=Europe/London:20201201T120000
DTSTAMP:20260422T120049
CREATED:20200921T104423Z
LAST-MODIFIED:20200921T104423Z
UID:18367-1606820400-1606824000@staging.medilinkmidlands.com
SUMMARY:CANCELLED Webinar: GDPR implications for international personal data transfers
DESCRIPTION:[box type=”shadow” align=”” class=”” width=””]We have unfortunately had to cancel this webinar due to circumstances beyond our control. We sincerely apologise for this inconvenience.  [/box] \nEarlier this year\, the European Court of Justice struck down the US Privacy Shield\, and although it focused on EU-US data transfers\, the ruling has caused widespread aftershocks for international personal data transfers within the EEA. International group companies using personal data\, or even non-international organisations which are using Cloud or other service providers in non-EEA countries (such as India or elsewhere)\, need to be aware of the implications arising from the ruling. \nFor life sciences businesses\, the kinds of data that may be affected could be data about individual patients and their treatment\, clinical trial data and information about staff\, research colleagues and physicians. Organisations have become so used to working digitally that they may not even fully appreciate when international data transfers are taking place. \nJagvinder Singh Kang\, International and UK Head of IT Law (CIPP/E\, CIPM) at Mills & Reeve considers what steps you can take to protect your organisation following the ruling. \nThis webinar will be relevant to all organisations involved in international personal data transfers from within the EEA\, whether to group companies\, service providers or other organisations. \nThere will also be an opportunity to ask the presenters questions\, when Jagvinder will be joined for a Q&A session by specialist Life Sciences Lawyer\, Stephanie Caird. \nDURATION: 1 hour \nPlease note that due to privacy restrictions this webinar will NOT be recorded and the presentation slides will not be available to download. \nThis free to attend webinar will be held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund. For further details please click here. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSPEAKER PROFILES: \n Jagvinder Singh Kang – International and UK Head of IT (CIPP/E\, CIPM) \nJagvinder is a market leading technology lawyer. He is featured in Legal 500’s official ‘Hall of Fame’ – which Legal 500 confirms: “highlights\, to clients\, the law firm partners who are at the pinnacle of the profession.” He has been recognised for 9 consecutive years in Legal 500’s ‘Elite List of Outstanding Technology Lawyers Nationwide’\, and consistently been ranked number one for IT and technology law by Legal 500 and Chambers & Partners for the same period. Jagvinder is a specialist technology and GDPR/data protection lawyer (CIPP/E\, CIPM)\, as well as a qualified software engineer (First Class BSc (Hons) Computer Science & Software Engineering) and he has completed the academic requirements for Chartered Engineer status as well. Furthermore\, he has over 20 years of technology law expertise from having advised on billions of pounds worth of UK and international technology transactions\, involving FTSE 100\, NASDAQ listed and other world-class corporates. He has also undertaken global\, European and UK GDPR compliance projects. \n  \n \nStephanie Caird – Commercial Lawyer \nStephanie is a lawyer in the life sciences practice\, with significant experience in data protection\, intellectual property\, commercial contracting and regulatory work. She supports a wide range of clients in the pharma and biotech\, medical devices and diagnostic sectors. Stephanie has worked in-house in various life sciences organisations\, giving her a unique insight into her clients. She uses this experience to deliver pragmatic and commercial advice. A key focus of her work is supporting clients on strategic decisions influenced by the regulatory framework and contracts covering IP\, research collaborations and Brexit related intra-group arrangements. \n 
URL:https://staging.medilinkmidlands.com/event/webinar-gdpr-implications-for-international-personal-data-transfers/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/erdflogo2.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201201T110000
DTEND;TZID=Europe/London:20201201T120000
DTSTAMP:20260422T120049
CREATED:20201007T131912Z
LAST-MODIFIED:20201007T131912Z
UID:18384-1606820400-1606824000@staging.medilinkmidlands.com
SUMMARY:WEBINAR: The Medicines and Medical Devices Bill - the UK regulatory environment following Brexit
DESCRIPTION:Join Mills & Reeve for this webinar where we will discuss the Medicines and Medical Devices Bill – the UK regulatory environment following Brexit. \nAs the end of the Brexit transition period approaches we see UK Government making plans to move forward as a standalone regulatory system. A central plank of these plans is the Medicines and Medical Devices Bill. This was published in February\, and is making its way through the Parliamentary process. Although existing EU law will be brought over into the UK system from 1 January 2021\, the Bill gives broad powers to the Health Minister to develop the law to fit UK priorities. Promoting fast-track approval of innovative medicines and technologies and reducing red tape\, as well as promoting UK-based industry\, will take on greater importance. \nFor medical devices\, the situation is made more complex by the forthcoming full implementation of the new EU regulations on medical devices and in vitro diagnostics. Likewise\, the EU clinical trials system is yet to be rolled out pending completion of the EMA’s new portal and database. The UK will have to decide how closely to track these systems\, while\, of course\, adopting its own administrative structures to implement them. \nDuring this webinar we will review the latest position\, and consider likely outcomes for the UK regulatory environment. \nThere will also be an opportunity to ask the presenters questions. \nDURATION: 1 hour \nThis free to attend event is held as part of the ACTIS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \n \nJames Fry\, Head of Life Sciences and Partner at Mills & Reeve \nJames heads the firm’s fast growing\, multi-disciplinary life sciences practice and focuses exclusively on this sector. The practice supports clients in the pharma and biotech\, medical device\, diagnostic\, medtech and digital health sub-sectors. James’ own practice focuses on intellectual property\, commercial contracting and regulatory work. \n  \n  \n  \n \nIsabel Teare\, Senior Legal Adviser at Mills & Reeve \nIsabel Teare is a Senior Legal Adviser at Mills & Reeve. She started her career in molecular biology\, and focuses on all aspects of life sciences law and regulation. \n  \n  \n  \n  \n 
URL:https://staging.medilinkmidlands.com/event/webinar-the-medicines-and-medical-devices-bill-the-uk-regulatory-environment-following-brexit/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/isabel-teare.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201202T110000
DTEND;TZID=Europe/London:20201202T120000
DTSTAMP:20260422T120049
CREATED:20201013T070828Z
LAST-MODIFIED:20201013T070828Z
UID:18388-1606906800-1606910400@staging.medilinkmidlands.com
SUMMARY:WEBINAR: How to plan and deliver a successful marketing campaign - for Life Sciences companies
DESCRIPTION:Join this webinar in partnership with Robin Bodicoat\, Marketing Director at Quotient Sciences\, to learn how to plan and deliver a successful marketing campaign. \nA successful marketing campaign will deliver the right message\, to the right audience through the right marketing channels. If you under-deliver in any of these areas your marketing will fail. This webinar will explore all 3 key elements that make up a campaign:\n• Target audience\n• Message\n• Media channel \nUsing practical industry focused examples you will learn how to identify and connect with your ideal target audience\, how to develop appropriate messaging that sets you apart from your competitors and what channels you need to use to get in front of your audience. \nThis webinar is suitable for anyone working in medical\, health\, medical technologies\, pharmaceutical or scientific sectors; who are responsible for promoting your products and services. \nThere will be an opportunity to ask any questions in a Q&A session following the presentation. \nSpeaker Profile \n Robin Bodicoat\, Marketing Director at Quotient Sciences \nRobin is the CIM qualified\, Marketing Director at Quotient Sciences\, a leading drug development services organization. He is also an active Board Member of the BMC (Business Marketing Club)\, which is the independent voice of the B2B marketing industry. He has 15+ years’ experience in Life Sciences\, Pharma and Healthcare\, with knowledge in marketing campaign planning and strategy\, and brand development. In 2017 he managed the global re-brand of Quotient Sciences.
URL:https://staging.medilinkmidlands.com/event/webinar-how-to-plan-and-deliver-a-successful-marketing-campaign-for-life-sciences-companies/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Robin-Bodicoat.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201208T150000
DTEND;TZID=Europe/London:20201208T163000
DTSTAMP:20260422T120049
CREATED:20201124T113532Z
LAST-MODIFIED:20201124T113532Z
UID:18463-1607439600-1607445000@staging.medilinkmidlands.com
SUMMARY:VIRTUAL EVENT: Medilink Midlands Annual General Meeting (AGM)
DESCRIPTION:The Medilink Midlands Annual General Meeting (AGM) will take place online on Tuesday 8 December. \nThis AGM brings together our Midlands membership\, which we have been working towards for some time. \nFollowing the formal presentations\, you will have the chance to meet and network with fellow members and representatives from the newly appointed Board of Directors. \nYou will also hear from two of our members sharing their recent experiences and how they have benefited from their membership. \nWe’re looking forward to welcoming our members to help launch Medilink Midlands and hope you can join us\, as we open the door to new networks\, business communities\, and opportunities across the Midlands. \nCLICK HERE TO SECURE YOUR PLACE\nPlease note: Non-members are welcome to attend the AGM. \nJoining details will be provided to delegates by a member of the Medlink Midlands events team once the online registration form has been completed.
URL:https://staging.medilinkmidlands.com/event/virtual-event-medilink-midlands-annual-general-meeting-agm/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Medilink-Midlands-Logo-orange-final.jpg
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201209T110000
DTEND;TZID=Europe/London:20201209T120000
DTSTAMP:20260422T120049
CREATED:20201026T114838Z
LAST-MODIFIED:20201026T114838Z
UID:18413-1607511600-1607515200@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Medtech Regulatory Special Interest Group (SIG) - Keeping Up With The Ever Changing Regulations
DESCRIPTION:The next Medtech Regulatory Special Interest Group (SIG) will take place online. Join us as we remove the confusion from the ever changing regulations including MDD\, IVDD\, AIMDD\, MDR\, IVDR\, UKCA & MRA\, and what it means to us in the UK. \nThe topics being discussed are:\n– Really Brief history of the Directives and their resurrected future: MDD\, IVDD\, AIMDD\n– The new MDR – current time line (less than 6 months to go)\n– The new IVDR – growing calls for a delay\n– The new UKCA Mark – for GB only!\n– What regulation applies to me?\n– Finding a Notified Body/ UK Approved Body \nThere will also be an opportunity to ask the presenter questions in a Q&A session. \nThis free to attend event is held as part of the ACTIS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \n  \nSpeaker Profile \nPeter Rose\, Managing Director\, PRQR Ltd \nPeter is the founder of PRQR Ltd. With 26 years of experience with Medical Devices and IVDs\, Peter has expertise covering Quality Assurance\, Regulatory Affairs\, Sterilisation\, Cleanrooms and Contamination Control. He is a Microbiologist\, Chartered biologist\, Member of the RSB\, Practitioner Member of the CQI and a Member of TOPRA. \n  \n  \n 
URL:https://staging.medilinkmidlands.com/event/medtech-regulatory-special-interest-group-sig-keeping-up-with-the-ever-changing-regulations/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/erdflogo2.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201215T100000
DTEND;TZID=Europe/London:20201215T110000
DTSTAMP:20260422T120049
CREATED:20201112T155710Z
LAST-MODIFIED:20201112T155710Z
UID:18435-1608026400-1608030000@staging.medilinkmidlands.com
SUMMARY:WEBINAR: Planning & Executing a post Covid-19 Business Recovery Plan
DESCRIPTION:Join this Medilink Midlands webinar in partnership with Christopher Demetriou\, Head of Business Advisory at Archimedia Accounts\, to learn how to Facilitate a Business Recovery Planning Session with your team\, focused on Recovering your business impacted through Covid. \nEvery business has been impacted to some extent by the Covid-19 pandemic. We want to ensure businesses recover from the pandemic as strongly as possible.\n• Do you want certainty about your new minimum weekly viable sales level to survive?\n• Do you want to learn how to further maximise opportunities and minimise vulnerabilities and risks?\n• Would you like to reduce the cashflow strain on your business?\n• Do you want clarity on the support and finance needed for your business at this challenging time? \nA Business Recovery Planning session requires you to reconsider all aspects of your business to ensure its best chance of recovery. Archimedia Accounts work with clients to develop a concise Business Recovery Plans and clarify the future direction of their business. \nWe’ll also show you how to revise your personal and business’s budget\, maximise support entitlements\, set goals for each department\, apply for bank finance (if needed) and ensure you feel supported throughout this recovery period. \nThis webinar will show you the exact Business Recovery Planning process we undertake with clients so you can do it yourself with your team. \nThere will be an opportunity to ask your questions directly to our speaker during a Q&A session. \nSpeaker Profile \nChristopher Demetriou\, Head of Business Advisory\, Archimedia Accounts \nChris has been delivering Business Plans over the last 8 years with many of Archimedia’s clients and in that time he has lead a number of those clients towards business success. His passion is continuously understanding business strategy & culture\, and helping our clients achieve their goals.
URL:https://staging.medilinkmidlands.com/event/webinar-planning-executing-a-post-covid-19-business-recovery-plan/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Chris-Demetriou.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201217T103000
DTEND;TZID=Europe/London:20201217T113000
DTSTAMP:20260422T120049
CREATED:20201123T124317Z
LAST-MODIFIED:20201123T124317Z
UID:18457-1608201000-1608204600@staging.medilinkmidlands.com
SUMMARY:East Midlands Academic Health Science Network Virtual Coffee Break
DESCRIPTION:Join the East Midlands Academic Health Science Network (EMAHSN) for a virtual coffee break on Thursday 17 December at 10:30am\, to have a chat about the complexity of health data and where to find publicly available data to support innovation in the NHS. \nThis informal gathering will be hosted by Glen Howard\, Programme Manager – Health Analytics and Informatics and you will have the opportunity to share your experiences and find out how the EMAHSN can help. \nNetworking opportunities are a key part of Medilink EM events and whilst the current COVID-19 crisis still restricts face to face events\, this online opportunity enables the life sciences community to still connect with one another. \nGrab a coffee\, a biscuit and join us. \nJoining details will be provided to delegates by a member of the Medilink Midlands events team once the online registration form has been completed. \nIf you have any topics that you’d like to discuss in future AHSN coffee breaks\, please feel free to email any suggestions to us by clicking here. \nChair: \n \n  \nGlen Howard\, Programme Manager – Health Analytics and Informatics \n  \n  \n 
URL:https://staging.medilinkmidlands.com/event/east-midlands-academic-health-science-network-virtual-coffee-break-4/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Glen-Howard-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201225T080000
DTEND;TZID=Europe/London:20201225T170000
DTSTAMP:20260422T120049
CREATED:20201104T102650Z
LAST-MODIFIED:20201104T102650Z
UID:18424-1608883200-1608915600@staging.medilinkmidlands.com
SUMMARY:Test Event Only
DESCRIPTION:test data \nERDF Event:\n[popup_trigger id=”1980″ tag=”button” classes=”eventbutton”]Book Now[/popup_trigger] \nNon ERDF Event:\n[popup_trigger id=”11059″ tag=”button” classes=”eventbutton”]Book Now[/popup_trigger] \nAHSN Event:\n[popup_trigger id=”6497″ tag=”button” classes=”eventbutton”]Book Now[/popup_trigger]
URL:https://staging.medilinkmidlands.com/event/test-event-only/
CATEGORIES:Medilink Midlands Event
END:VEVENT
END:VCALENDAR